Science

Innovations, adaptations, and accelerations in the delivery of HIV services during COVID-19 – The Lancet

Summary

During 2020, the COVID-19 pandemic disrupted the delivery of HIV prevention and treatment services globally. To mitigate the negative consequences of the pandemic, service providers and communities adapted and accelerated an array of HIV interventions to meet the needs of people living with HIV and people at risk of acquiring HIV in diverse geographical and epidemiological settings. As a result of these adaptations, services such as HIV treatment showed programmatic resilience and remained relatively stable in 2020 and into the first half of 2021. To review lessons learned and suggest which novel approaches to sustain, UNAIDS convened a virtual consultation on Feb 1–2, 2022, which was attended by a range of stakeholders from different areas of global HIV response.

Introduction

The effect of epidemics and pandemics extends beyond direct effects from the diseases concerned. By the end of June, 2022, COVID-19 had caused more than 500 million cases and 6 million deaths, both widely considered to be underestimated.

The pandemic’s true death toll: millions more than official counts.

COVID-19 Excess Mortality Collaborators
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21.

Early concerns were that HIV incidence and AIDS-related mortality could increase from the disruption of treatment and prevention programmes.

The pandemic’s true death toll: millions more than official counts.

  • Jewell BL
  • Mudimu E
  • Stover J
  • et al.
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.

In 2020 and 2021, WHO issued recommendations for managing and simplifying HIV and other health services in response to COVID-19.

WHO
COVID-19: operational guidance for maintaining essential health services during an outbreak: interim guidance.

WHO
Updated recommendations on service delivery for the treatment and care of people living with HIV.

Stakeholders took diverse actions to mitigate negative consequences of the pandemic and document lessons learned, and HIV treatment continuity appears to have remained stable during 2020.

  • Grimsrud A
  • Ehrenkranz P
  • Sikazwe I
Silver linings: how COVID-19 expedited differentiated service delivery for HIV.

  • Mehta N
  • Stewart A
  • Fisher K
  • Ghosh S
  • Santos L
  • Harvey P
Impact of COVID-19 on HIV treatment interruption in seven PEPFAR countries, April–June 2020.

UNAIDS
Prevailing against pandemics by putting people at the centre—World AIDS Days report 2020.

UNAIDS
In danger: UNAIDS Global AIDS Update 2022.

UNAIDS convened a virtual consultation on Feb 1–2, 2022, to assess the effect of COVID-19 on HIV services; review innovations, adaptations, and accelerations in practice; suggest which novel approaches to sustain; and propose further implementation research. The meeting was co-sponsored by WHO, the International AIDS Society (IAS), The Global Fund, Columbia University’s ICAP programme, and the President’s Emergency Plan for AIDS Relief. Representatives from networks of people living with or disproportionately affected by HIV shared their experiences, and group discussions focused on adaptations and knowledge gaps. Approximately 60 people attended the meeting from Europe, the Americas, Asia, and Africa.

Challenges to service delivery

Complementing published experiences,

  • Grimsrud A
  • Ehrenkranz P
  • Sikazwe I
Silver linings: how COVID-19 expedited differentiated service delivery for HIV.

  • Mehta N
  • Stewart A
  • Fisher K
  • Ghosh S
  • Santos L
  • Harvey P
Impact of COVID-19 on HIV treatment interruption in seven PEPFAR countries, April–June 2020.

  • Shi L
  • Tang W
  • Hu H
  • et al.
The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China.

Pollard R, Gopinath U, Reddy Y, et al. HIV service delivery to key populations in the time of COVID-19: experiences from India. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

The Global Fund
The impact of COVID-19 on HIV, TB, and malaria services and systems for health. A snapshot from 502 health facilities across Africa and Asia.

Peck M, Ong K, Lucas T, et al. Characterizing the effect of the COVID-19 pandemic on PEPFAR-supported voluntary medical male circumcision services, 2020. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  • Boyd AT
  • Jahun I
  • Dirlikov E
  • et al.
Expanding access to HIV services during the COVID-19 pandemic—Nigeria, 2020.

Mwanza M, Mbewe P, Mwale C, et al. Scaling up multi-month dispensation (MMD) of antiretroviral therapy in response to COVID-19 in Zambia. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  • Matambanadzo P
  • Busza J
  • Mafaune H
  • et al.
“It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19.

WHO
Third round of the global pulse survey on continuity of essential health services during the COVID-19 pandemic. Interim report.

data were shared on service disruptions and mitigations in relation to HIV testing, antiretroviral therapy (ART), viral load testing, viral load suppression, pre-exposure prophylaxis (PrEP), prevention of vertical transmission, and voluntary medical male circumcision. Under-recognised factors that restricted HIV service delivery included staff shortages from illness, staff redeployment towards COVID-19, disruptions of public transportation services to travel to health facilities, and use of health facilities as isolation centers. The need for personal protective equipment (PPE) and other supplies increased costs.

Representatives from different groups, including young people, people living with HIV, and people from key populations—people who inject drugs; transgender people, gay, bisexual, and other men who have sex with men; and sex workers—shared experiences related to the provision of services during the COVID-19 pandemic. They reported challenges including job losses and dropout or exclusion from school, and increased social vulnerability, poverty, and homelessness. Sexual harassment and gender-based violence were also reported to have increased.

  • Emandi R
  • Encarnacion J
  • Seck P
  • Tabaco RJ
Measuring the shadow epidemic: violence against women during COVID 19.

Young people reported needing accurate information about COVID-19, but also about other health, economic, and social issues. For people who use drugs, interruption of harm reduction services due to closure of services and restrictive regulations were reported as frequent by meeting participants. Sex workers reported increased harassment, violence, reduced HIV prevention and support services, reduced income because of lockdowns and travel restrictions, and reduced access to social protection and emergency government responses due to criminalisation.

How HIV services adapted

Three important themes emerged during the pandemic: resilience and bounce-back capacity of many HIV services; the commonality of mitigation interventions in different technical areas; and the fact that some adaptations were introduced before COVID-19, but only scaled up during COVID-19, such as multimonth dispensing of ART. The acceleration of approaches, such as HIV self-testing, multimonth dispensing of ART and PrEP and other differentiated service delivery models, flexible harm reduction, and mental health services, were examples of successful adaptations.

  • Grimsrud A
  • Ehrenkranz P
  • Sikazwe I
Silver linings: how COVID-19 expedited differentiated service delivery for HIV.

Mwanza M, Mbewe P, Mwale C, et al. Scaling up multi-month dispensation (MMD) of antiretroviral therapy in response to COVID-19 in Zambia. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  • Matambanadzo P
  • Busza J
  • Mafaune H
  • et al.
“It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19.

  • Csák R
  • Shirley-Beavan S
  • McHenry AE
  • Daniels C
  • Burke-Shyne N
Harm reduction must be recognised an essential public health intervention during crises.

Community-based and community-led interventions, use of telemedicine (ie, the provision of remote clinical services), the generation of demand for health services, and integration of COVID-19 information, vaccination, and provision of PPE were other key innovations and adaptations. Community networks reported that, in many settings, community-led responses were the first to ensure that the needs of their community were met, including the transportation of antiretrovirals from clinics or hospitals to homes, and the distribution of needles, syringes, condoms, and PPE. Community networks also assisted with medical care and transportation when ambulances were unavailable. Community networks fundraised to ensure the basic needs of people who lost jobs or housing during the pandemic, often without additional external support.

UNAIDS
Holding the line: communities as first responders to COVID-19 and emerging health threats.

Facility-based modifications aimed to decongest health-care settings and reduce visits, travel, and physical interactions.

Mwanza M, Mbewe P, Mwale C, et al. Scaling up multi-month dispensation (MMD) of antiretroviral therapy in response to COVID-19 in Zambia. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

Rodriguez-Iantorno P, Cecchini D, Mauas R, et al. Successful implementation of telemedicine and pharmacy enhanced HIV services as response to COVID-19 quarantine among health insured patients in Argentina. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  • Maatouk I
  • Nakib ME
  • Assi M
  • et al.
Community-led HIV self-testing for men who have sex with men in Lebanon: lessons learned and impact of COVID-19.

Fernando N, Gleason M, Amzel A, Vrazo A, Srivastava M. The impact of the COVID-19 pandemic on uptake of multi-month dispensing (MMD) of antiretroviral therapy for children living with HIV: a multicountry analysis. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

Several adapted practices have been highlighted as essential by both The Global Fund and an IAS journal supplement.

  • Grimsrud A
  • Ehrenkranz P
  • Sikazwe I
Silver linings: how COVID-19 expedited differentiated service delivery for HIV.

The Global Fund
COVID-19 information note: considerations for Global Fund support for HIV.

Data from Nigeria suggested that a focused effort on HIV testing and treatment, despite COVID-19, could result in rapid expansion of HIV testing and treatment.

  • Boyd AT
  • Jahun I
  • Dirlikov E
  • et al.
Expanding access to HIV services during the COVID-19 pandemic—Nigeria, 2020.

Boyd AT, Jahun I, Dirlikov E, et al. Circumventing COVID-19 challenges while expanding access to HIV services: lessons from the Nigeria antiretroviral therapy (ART) surge, February–September 2020. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

Appropriately funded programmes, including those with important external funding, did better than programmes with less international support, particularly for key populations.

Regarding services providing antiretrovirals for adults, adolescents, and children, essential adaptations were multimonth dispensing, community-based treatment initiation and maintenance, and PrEP initiation after HIV self-testing. Community organisations led by peers were essential in providing psychosocial support and collecting data, and most importantly ensuring that the most disproportionately affected groups, such as key populations, could receive uninterrupted access to services. Use of information technology was essential for outreach and generating demand for HIV services. Community services were able to integrate services for comorbidities. Knowledge gaps included how to deal with advanced HIV disease, how to address needs of key populations, optimum monitoring of people who use PrEP, generating tailored approaches to HIV prevention supplies, clarification of ideal intervals between ART refills, and how to integrate with and assure COVID-19 services.

Essentials for vertical transmission prevention focused on decentralisation and task sharing and shifting (ie, redistributing tasks from highly trained clinical health-care providers to providers with less training). Multimonth dispensing of drugs was tied to antenatal care and child vaccination schedules. PrEP for members of key populations and the use of navigators to guide clients through the health-care system were emphasised during the meeting discussions. Point-of-care diagnostics, such as those used for early infant diagnosis, were needed for increased community-based services. Use of virtual platforms and communications was essential. Some requirements highlighted by the pandemic were longstanding, such as need for addressing HIV breastfeeding transmission, low HIV testing rates among infants and children, point-of-care early infant diagnosis, defining the role of long-acting ART preparations, and elimination of user fees in west and central Africa that impede access to services.

Direct service delivery that was community-led addressed not only ART, but also food, hygiene packs, and other essentials. Community-led newsletters conveyed important information, including about COVID-19 prevention. Virtual platforms provided social support and helped address mental health requirements. For people who use drugs, rapid decarceration was shown to be feasible as a COVID-19 risk-reduction strategy relevant to this population that is over-represented in detention facilities. Adaptations also included simplified prescribing, take-home opioid agonist therapy, increased access to naloxone, and the provision of food and PPE.

Conclusions

Implementation science should address acceptability, sustainability, and cost of such adaptations in the long term. Several adaptations could be implemented in high-income settings. Overall, these adaptations emphasise client autonomy, self-care, and decentralisation of health-care provision to the community level. Increased use of electronic communications, virtual platforms, and mass and social media for health education, staff supervision, and client monitoring can lessen direct interaction with health facilities. Further differentiated service delivery approaches are emerging, such as same day PrEP after self-testing for HIV, and in community settings. Efficiencies could be gained by further integration of health service delivery. Continued investment in the strengthening of health systems will be important to sustain the scale up of multimonth dispensing in resource-limited settings.

This collective experience has reiterated the centrality of communities in the HIV response, the importance of maintaining standards of human rights, service access, and addressing HIV-related stigma and discrimination, the need to address unmet requirements of key populations, children, adolescents, and men, and the crucial role of community-led organisations. The effect of the COVID-19 pandemic on HIV service delivery has provided important lessons for further upscaling of HIV services, as well as preparedness for future health shocks.

Contributors

EM, PDG, PG-F, LF, and KMD conceptualised the manuscript; EM approved the final version. MD, WES, IZ, AK, SC, FRA, CM, EC, AG, NM, AT, PDG, and P“A”C-C provided a critical review. WEL, IZ, AK, SC, and PDG provided commentary. KMD wrote the original draft, including review and editing.

Declaration of interests

We declare no competing interests.

Acknowledgments

We thank all participants and presenters who contributed to the UNAIDS virtual consultation on HIV service innovations in COVID times on Feb 1–2, 2022, the Ministry of Health of Germany for their support, and Cleiton de Lima and Elani Nassif for their invaluable contributions to the planning and moderation of key meeting sessions.

References

  1. 1.

    The pandemic’s true death toll: millions more than official counts.

    Nature. 2022; 601: 312-315

  2. 2.
    • COVID-19 Excess Mortality Collaborators

    Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21.

    Lancet. 2022; 399: 1513-1536

  3. 3.
    • Jewell BL
    • Mudimu E
    • Stover J
    • et al.

    Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.

    Lancet HIV. 2020; 7: e629-e640

  4. 4.

    COVID-19: operational guidance for maintaining essential health services during an outbreak: interim guidance.

    World Health Organization, Geneva2020

  5. 5.

    Updated recommendations on service delivery for the treatment and care of people living with HIV.

    World Health Organization, Geneva2021

  6. 6.
    • Grimsrud A
    • Ehrenkranz P
    • Sikazwe I

    Silver linings: how COVID-19 expedited differentiated service delivery for HIV.

    J Int AIDS Soc. 2021; 24e25807

  7. 7.
    • Mehta N
    • Stewart A
    • Fisher K
    • Ghosh S
    • Santos L
    • Harvey P

    Impact of COVID-19 on HIV treatment interruption in seven PEPFAR countries, April–June 2020.

    J Int AIDS Soc. 2021; 24: 76

  8. 8.

    Prevailing against pandemics by putting people at the centre—World AIDS Days report 2020.

    Joint United Nations Programme on HIV/AIDS, Geneva2020

  9. 9.

    In danger: UNAIDS Global AIDS Update 2022.

    Joint United Nations Programme on HIV/AIDS, Geneva2022

  10. 10.
    • Shi L
    • Tang W
    • Hu H
    • et al.

    The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China.

    BMC Infect Dis. 2021; 21: 768

  11. 11.

    Pollard R, Gopinath U, Reddy Y, et al. HIV service delivery to key populations in the time of COVID-19: experiences from India. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  12. 12.
    • The Global Fund

    The impact of COVID-19 on HIV, TB, and malaria services and systems for health. A snapshot from 502 health facilities across Africa and Asia.

    The Global Fund, Geneva2021

  13. 13.

    Peck M, Ong K, Lucas T, et al. Characterizing the effect of the COVID-19 pandemic on PEPFAR-supported voluntary medical male circumcision services, 2020. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  14. 14.
    • Boyd AT
    • Jahun I
    • Dirlikov E
    • et al.

    Expanding access to HIV services during the COVID-19 pandemic—Nigeria, 2020.

    AIDS Res Ther. 2021; 18: 62

  15. 15.

    Mwanza M, Mbewe P, Mwale C, et al. Scaling up multi-month dispensation (MMD) of antiretroviral therapy in response to COVID-19 in Zambia. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  16. 16.
    • Matambanadzo P
    • Busza J
    • Mafaune H
    • et al.

    “It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19.

    J Int AIDS Soc. 2021; 24e25813

  17. 17.

    Third round of the global pulse survey on continuity of essential health services during the COVID-19 pandemic. Interim report.

    World Health Organization, Geneva2022

  18. 18.
    • Emandi R
    • Encarnacion J
    • Seck P
    • Tabaco RJ

    Measuring the shadow epidemic: violence against women during COVID 19.

    UN Women, Geneva2021

  19. 19.
    • Csák R
    • Shirley-Beavan S
    • McHenry AE
    • Daniels C
    • Burke-Shyne N

    Harm reduction must be recognised an essential public health intervention during crises.

    Harm Reduct J. 2021; 18: 128

  20. 20.

    Holding the line: communities as first responders to COVID-19 and emerging health threats.

    Joint United Nations Programme on HIV/AIDS, Geneva2021

  21. 21.

    Rodriguez-Iantorno P, Cecchini D, Mauas R, et al. Successful implementation of telemedicine and pharmacy enhanced HIV services as response to COVID-19 quarantine among health insured patients in Argentina. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  22. 22.
    • Maatouk I
    • Nakib ME
    • Assi M
    • et al.

    Community-led HIV self-testing for men who have sex with men in Lebanon: lessons learned and impact of COVID-19.

    Health Res Policy Syst. 2021; 19: 50

  23. 23.

    Fernando N, Gleason M, Amzel A, Vrazo A, Srivastava M. The impact of the COVID-19 pandemic on uptake of multi-month dispensing (MMD) of antiretroviral therapy for children living with HIV: a multicountry analysis. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.

  24. 24.
    • The Global Fund

    COVID-19 information note: considerations for Global Fund support for HIV.

    The Global Fund, Geneva2020

  25. 25.

    Boyd AT, Jahun I, Dirlikov E, et al. Circumventing COVID-19 challenges while expanding access to HIV services: lessons from the Nigeria antiretroviral therapy (ART) surge, February–September 2020. 11th International AIDS Society Conference on HIV Science; July 18–21, 2021.